EndoRel Biosciences Revenue

Biotechnology Research • Portland, Oregon, United States • 1-10 Employees

EndoRel Biosciences revenue & valuation

Annual revenue	$171,110
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$547,552
Total funding	No funding

Key Contact at EndoRel Biosciences

Jeremy Bushman

Founder

Company overview

Headquarters	2828 S Corbett Ave, Portland, Oregon 97201, US
Website	endorelbio.com
Founded	2021
Employees	1-10
Socials

About EndoRel Biosciences

EndoRel Biosciences is an early-stage startup with proprietary technology to enhance intracellular drug delivery. By combining our Endosome to Cytosol Delivery (ECD) technology with small molecule, antisense, or protein-based drugs, or complementary delivery technologies including nanoparticles, we provide our customers (partners and collaborators) with a powerful tool for creating the next generation of therapeutics supporting human health and well-being.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

EndoRel Biosciences has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

EndoRel Biosciences has never raised funding before.

EndoRel Biosciences Tech Stack

Discover the technologies and tools that power EndoRel Biosciences's digital infrastructure, from frameworks to analytics platforms.

HTTP/3

Miscellaneous

PHP

Programming languages

HSTS

Security

WordPress

Blogs

Divi

Page builders

MySQL

Databases

RSS

Miscellaneous

Priority Hints

Performance

Google Font API

Font scripts

Microsoft 365

Frequently asked questions

EndoRel Biosciences is located in Portland, Oregon, US.

EndoRel Biosciences generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.

EndoRel Biosciences has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

EndoRel Biosciences was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.

EndoRel Biosciences has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at EndoRel Biosciences

Jeremy Bushman

Founder

4.8

40,000 users